Elon Musk predicts robots will soon surpass human surgeons, citing Neuralink's precision electrode implantation as a prime example. This bold claim ha ...

BCIs bridge the gap in neurological care, translating brain activity into commands for communication and device control, ...

Elon Musk’s brain implant company Neuralink is planning to raise about $500 million at a valuation of $8.5 billion.

Elon Musk's brain implant company Neuralink is planning to raise about $500 million at a pre-money valuation of $8.5 billion, ...

+ How the federal government is tracking changes in the supply of street drugs. A new harm reduction initiative is helping ...

The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s ...

Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

With 3 implants done, Beinao joins Neuralink, while other players such as Synchron, Blackrock Neurotech, Paradromics, and Precision Neuroscience are further into their clinical journey.

US BCI company Synchron, whose investors include billionaires Jeff Bezos and Bill Gates, is currently the global leader in terms of human trials with 10 patients – six in the US and four in ...

Neuralink, Synchron, and Neuracle are expanding clinical trials and trying to zero in on an actual product.

Right now, the US-based Synchron--backed by heavyweights like Jeff Bezos and Bill Gates -- leads with 10 patients across the US and Australia. Neuralink trails with three. The Beinao No.1 ...